Allstate (ALL) News Today

The Allstate Corporation (NYSE: ALL) has decreased as investors weigh bullish analyst targets against concerns about valuation, sustainability of recent returns, and insider selling. The company’s latest quarterly results were strong, with earnings significantly exceeding expectations and revenue rising year over year, but recent developments have produced mixed signals.

• Positive Sentiment: JPMorgan raised its price target for Allstate from $282 to $292 and maintained an “overweight” rating, implying meaningful upside based on its current valuation. Benzinga report
• Positive Sentiment: Piper Sandler also increased its price target, lifting it from $268 to $300 and reiterating an “overweight” rating. The revision suggests the firm expects continued earnings strength or improved valuation support. Ticker Report article
• Neutral Sentiment: Allstate is preparing its Allie platform as part of an agentic artificial-intelligence strategy. The initiative could improve productivity and customer service over time, although its financial impact remains uncertain. Allstate preps Allie platform to drive agentic AI strategy
• Negative Sentiment: Citi downgraded Allstate to “sell”, arguing that the insurer’s recent operating returns appear “unsustainable.” The call challenges the durability of the company’s recent profit performance. Allstate cut to sell at Citi
• Negative Sentiment: Insider John E. Dugenske sold 32,996 shares worth approximately $8.9 million, reducing his position by about 72%. While insider sales can be planned for personal reasons, the size of the transaction may weigh on sentiment. SEC insider transaction filing
• Negative Sentiment: DOWLING & PARTN projected FY2028 EPS of $25.50, below the current consensus estimate of $31.40 for the full year. The lower forecast raises concerns about longer-term earnings growth.